Here’s what you should know.
1. Both Mylan’s EpiPen and Impax’s Adrenaclick auto injector were placed on the drug shortages list.
2. Both companies are facing manufacturer delays.
3. Mylan released a statement saying it is receiving continuous supply from its manufacturer.
4. Pfizer, owner of the manufacturer, said, “Pfizer takes very seriously the importance of EpiPen to everyone who needs it, and we are working tirelessly to increase production as rapidly as possible.” Pfizer has increased its EpiPen production over the last few months.
More articles on supply chain:
California bill allowing government to determine healthcare pricing met with fierce opposition
Common deficiencies cited by AAAASF and how to fix them — Every OR must be equipped with an AED or standard defibrillator
Total joints in ASCs: 4 common questions answered
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.